Oct 30 2014 |
Medical Device Update: Distinguishing Medical Device Recalls from Medical Device Enhancements |
Morgan, Lewis & Bockius LLP |
Oct 29 2014 |
Marijuana Users in Michigan Eligible for Unemployment |
Proskauer Rose LLP |
Oct 29 2014 |
Progress Update: House Energy and Commerce Committee (E&C) 21st Century Cures Initiative |
McDermott Will & Emery |
Oct 29 2014 |
Ebola Exclusions from Commercial Insurance Policies |
Mintz |
Oct 29 2014 |
U.S. Immigration Policy Catches Up with Assisted Reproductive Technology |
Mintz |
Oct 29 2014 |
Recent Trends in Medical Device Patent Litigation at the ITC — Part 1 |
Covington & Burling LLP |
Oct 29 2014 |
Government Looking to Existing Procurement Vehicles to Stem Ebola Threat |
Covington & Burling LLP |
Oct 28 2014 |
Texas Federal Jury Sides with J&J’s DePuy In First Pinnacle Hip Implant Trial |
Covington & Burling LLP |
Oct 28 2014 |
CMS Releases Preliminary 2015 Clinical Laboratory Fee Schedule Rates |
McDermott Will & Emery |
Oct 28 2014 |
Bostwick Laboratories Agrees to Pay U.S. Government $6.05 Million for Allegedly Violating the Anti-Kickback Statue; Whistleblower to Receive Reward |
Tycko & Zavareei LLP |
Oct 28 2014 |
Michigan Medical Marijuana Law Allows Employees Terminated for Positive Marijuana Test Results to Receive Unemployment Benefits |
Jackson Lewis P.C. |
Oct 27 2014 |
A Review of the Status of Biosimilars in the U.S. |
Michael Best & Friedrich LLP |
Oct 25 2014 |
EPA Updates Toxic Substances Control Act (TSCA) Work Plan for Chemical Assessments |
Beveridge & Diamond PC |
Oct 24 2014 |
FTC Takes Action Against Unsubstantiated Caffeine-Infused Shapewear Weight-Loss Claims |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 23 2014 |
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 23, 2014 |
Mintz |
Oct 23 2014 |
Uncertain Times for Biotech and Pharma Patents |
Vedder Price |
Oct 23 2014 |
California Battle of the Experts Still Brewin’ in Starbucks Trial |
Mintz |
Oct 22 2014 |
Mushroom Growers Denied Capper-Volstead Antitrust Immunity |
McDermott Will & Emery |
Oct 22 2014 |
California Court Has a Bone to Pick with Male Enhancement Pill Maker |
Proskauer Rose LLP |
Oct 21 2014 |
Ebola Spurs Global Cooperation to Prevent, Detect and Respond to Future Health Crises |
Covington & Burling LLP |
Oct 21 2014 |
Health Care Researchers Publish on the Implications of New Provider Payment Models on Innovative Medical Technology |
Analysis Group, Inc. |
Oct 21 2014 |
Biotechnology Industry Organization (BIO) Provides Supplemental Comments on PTO s.101 Guidelines |
Schwegman, Lundberg & Woessner, P.A. |
Oct 21 2014 |
FDA Issues Final Guidance on Distinguishing Medical Device Recall from Product Enhancement |
Barnes & Thornburg LLP |
Oct 20 2014 |
Time is of the Essence: Review Your Workplace Policies Before Medical Marijuana is Available in IL |
Heyl, Royster, Voelker & Allen, P.C. |
Oct 20 2014 |
Colorado Supreme Court Set To Decide Seminal Drug Testing Case |
Proskauer Rose LLP |
Oct 20 2014 |
IPR (Inter Partes Review) Challenge to Pharmaceutical Compound Patent Denied |
Armstrong Teasdale |
Oct 20 2014 |
The New EU Clinical Trials Regulation Aims at Harmonization and Transparency |
McDermott Will & Emery |
Oct 18 2014 |
Confronting Ebola Concerns in the Workplace |
Jackson Lewis P.C. |
Oct 17 2014 |
Front End Changes and, Again, More Direct and Indirect Remuneration (DIR) Columns |
Mintz |
Oct 17 2014 |
Professional License Applications Can Be Denied Based on Unintentional Errors |
Faegre Drinker |
Oct 17 2014 |
The Incredible Shrinking Red Bull Refund: How Should Courts Verify Class Membership? |
Mintz |
Oct 16 2014 |
Revocation of Ex-Convict’s Job Offer Did Not Violate State Law, Says PA Court |
Proskauer Rose LLP |
Oct 15 2014 |
New News on Ebola May Require Changes in Employer Procedures |
Proskauer Rose LLP |
Oct 14 2014 |
Protecting Healthcare and Other Employees From Ebola |
Proskauer Rose LLP |
Oct 14 2014 |
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 2014 |
Mintz |